Gabriel Tayguara Silveira Guerreiro

Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Fonseca et al. · Hepatology International · 2021 · 62 citations

Cardiovascular Disease, Biopsy-proven Nafld, Public Health +7

Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

Alberto Queiróz Farias, A. Vilalta, Patrícia Momoyo Zitelli et al. · Gastroenterology · 2023 · 44 citations · Full text

Hepatoprotective Effect of Probiotic <i>Lactobacillus rhamnosus</i> GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish

Juliana Paula Bruch Bertani, Carolina Uribe Cruz, Amanda Pasqualotto et al. · Journal of the American College of Nutrition · 2019 · 27 citations

Firmicutes/Bacteroidetes and Firmicutes/Proteobacteria ratios are associated with worse prognosis in a cohort of Latin American patients with cirrhosis

Augusto Mantovani, Larisse Longo, Rutiane Ullmann Thoen et al. · Clinics · 2024 · 14 citations · Full text

Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats

Larisse Longo, Josimar Macedo de Castro, Melina Belén Keingeski et al. · Nutrition · 2023 · 10 citations